Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cochlear implants

This article was originally published in The Gray Sheet

Executive Summary

Pediatric cochlear implantation accrues net expected savings of $53,198 over a child's lifetime, Andre Cheng, MD/PhD, Johns Hopkins University, et al., concludes in an Aug. 16 Journal of the American Medical Association article describing the first cost-utility study of profoundly deaf pediatric patients and their parents using U.S. cost data. Scores from three quality of life measures, based on a scale from 0 to 1, demonstrate improvement over pre-implantation status: health utility index (39%, n=22); visual analog scale (27%, n=78) and time trade-off (22%, n=40). Cochlear Corp.' s Nucleus-24 and Advanced Bionics' Clarion implants were used in the study
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013749

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel